Résumé
Des progrès très significatifs ont été réalisés au cours des deux dernières décennies dans le domaine de l’oncogénétique digestive et notamment des formes héréditaires des cancers colorectaux. Ils sont abordés dans cet article et sont dominés par la description récente d’une nouvelle entité, la polypose adénomateuse associée à MYH, et par l’amélioration significative de nos connaissances relatives aux différents aspects du syndrome de Lynch: stratégie diagnostique, corrélations phénotype-génotype, mutations causales, prise en charge…
Abstract
This review will be focused on the recent advances in the field of hereditary colorectal cancer syndromes. They are dominated by the identification of the new entity called « MYH-associated polyposis » and by significant advances in different aspects of Lynch syndrome: diagnosis, molecular basis, phenotypic-genotypic correlations, surveillance…
Références
Buecher B, Groupe génétique et cancer, Fédération nationale des centres de lutte contre le cancer (2007) Les polyposes adénomateuses associées à MYH. Gastroenterol Clin Biol 31:775–778
Hearle N, Schumacher V, Menko FH, et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 6:3209–3215
Giardiello FM, Trimbath JD (2006) Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 4:408–415
Buecher B, Bézieau S, Dufilhol C, et al (2007) Les polypes festonnés colorectaux: une entité revisitée. Gastroenterol Clin Biol 31:39–54
Olschwang S, Bonaïti C, Feingold J, et al (2004) Identification et prise en charge du syndrome HNPCC (hereditary non-polyposis colon cancer), prédisposition héréditaire aux cancers du côlon, du rectum et de l’utérus. Bull Cancer 91:303–315
Lu KH, Schorge JO, Rodabaugh KJ, et al (2007) Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. J Clin Oncol 25:5158–164
Garg K, Soslow RA (2009) Lynch syndrome (hereditary nonpolyposis colorectal cancer) and endometrial carcinoma. J Clin Pathol 62:679–684
Westin SN, Lacour RA, Urbauer DL, et al (2008) Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. J Clin Oncol 26:5965–5971
Malander S, Rambech E, Kristoffersson U, et al (2006) The contribution of the hereditary non-polyposis colorectal cancer syndrome to the development of ovarian cancer. Gynecol Oncol 101:238–243
Jensen KC, Mariappan MR, Putcha GV, et al (2008) Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Am J Surg Pathol 32:1029–1037
Lu KH, Dinh M, Kohlmann W, et al (2005) Gynecologic cancer as a “sentinel cancer” for women with hereditary non-polyposis colorectal cancer syndrome. Obstet Gynecol 105:569–574
Ponti G, Ponz de Leon M (2005) Muir-Torre syndrome. Lancet Oncol 6:980–987
Hamilton SR, Liu B, Parsons RE, et al (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332:839–847
Di Fiore F, Charbonnier F, Martin C, et al (2004) Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet 41:18–20
Ligtenberg MJL, Kuiper RP, Chan TL, et al (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nature Genet 41:113–117
Kovacs ME, Papp J, Szentirmay Z, et al (2009) Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat 30:197–203
Niessen RC, Hofstra RMW, Westers H, et al (2009) Germ line hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer 48:737–744
Senter L, Clendenning M, Sotamaa K, et al (2008) The clinical phenotype of Lynch syndrome due to germ line PMS2 mutations. Gastroenterology 135:419–428
East JE, Suzuki N, Stavrinidis M, et al (2008) Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut 57:65–67
Renkonen-Sinisalo L, Bützow R, Leminen A, et al (2006) Surveillance for endometrial cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 120:821–824
Jass RJ (2006) Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 12:4943–4950
Lindor NM, Rabe K, Petersen GM, et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979–1985
Llor X, Pons E, Xicola RM, et al (2005) Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11:7304–7310
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Buecher, B., Molière, D. & De Pauw, A. Les nouveautés dans les formes héréditaires des cancers colorectaux. Colon Rectum 3, 222–229 (2009). https://doi.org/10.1007/s11725-009-0182-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11725-009-0182-4